Evidence map›Paper›PMID 29123096›Full record

ArticleNature communications2017

ATR kinase inhibition induces unscheduled origin firing through a Cdc7-dependent association between GINS and And-1.

Tatiana Moiseeva, Brian Hood, Sandy Schamus, Mark J O'Connor, Thomas P Conrads, Christopher J Bakkenist

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 104 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. ATR kinase inhibitors induce mitochondrial fission in CD8bioRxiv : the preprint server for biology · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Tatiana MoiseevaDepartment of Radiation Oncology, University of Pittsburgh School of Medicine, Hillman Cancer Center, Research Pavilion, Suite 2.6, 5117 Centre Avenue, Pittsburgh, PA, 15213-1863, USA.ORCID http://orcid.org/0000-0002-1181-9519
Brian HoodInova Schar Cancer Institute, Inova Center for Personalized Health, Annandale, VA, 22003, USA.
Sandy SchamusDepartment of Radiation Oncology, University of Pittsburgh School of Medicine, Hillman Cancer Center, Research Pavilion, Suite 2.6, 5117 Centre Avenue, Pittsburgh, PA, 15213-1863, USA.
Mark J O'ConnorDNA Damage Response Biology, Innovative Medicines and Early Clinical Development, Little Chesterford, Saffron Walden, CB10 1XL, UK.
Thomas P ConradsInova Schar Cancer Institute, Inova Center for Personalized Health, Annandale, VA, 22003, USA.
Christopher J BakkenistDepartment of Radiation Oncology, University of Pittsburgh School of Medicine, Hillman Cancer Center, Research Pavilion, Suite 2.6, 5117 Centre Avenue, Pittsburgh, PA, 15213-1863, USA. bakkenistcj@upmc.edu.
Inova Health System · USUPMC Hillman Cancer Center · USUniversity of Pittsburgh · US

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Jessie Nedrow · 1988 to 2026
$158.0M
Vitamin D3 Modulation of Inflammation and Lung Cancer RiskP50CA090440 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DACIC, SANJA · 2001 to 2015
$34.6M
DNA damage signaling to immune checkpointsR01CA204173 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BAKKENIST, CHRISTOPHER J. · 2017 to 2021
$1.8M
NCI NIH HHS P30 CA047904NCI NIH HHS P50 CA090440NCI NIH HHS R01 CA204173
6 · The paper itself

Abstract

ATR kinase activity slows replication forks and prevents origin firing in damaged cells. Here we describe proteomic analyses that identified mechanisms through which ATR kinase inhibitors induce unscheduled origin firing in undamaged cells. ATR-Chk1 inhibitor-induced origin firing is mediated by Cdc7 kinase through previously undescribed phosphorylations on GINS that induce an association between GINS and And-1. ATR-Chk1 inhibitor-induced origin firing is blocked by prior exposure to DNA damaging agents showing that the prevention of origin firing does not require ongoing ATR activity. In contrast, ATR-Chk1 inhibitor-induced origins generate additional replication forks that are targeted by subsequent exposure to DNA damaging agents. Thus, the sequence of administration of an ATR kinase inhibitor and a DNA damaging agent impacts the DNA damage induced by the combination. Our experiments identify competing ATR and Cdc7 kinase-dependent mechanisms at replication origins in human cells.

Indexed as

Ataxia Telangiectasia Mutated ProteinsCell Cycle ProteinsCell Line, TumorCheckpoint Kinase 1Chromosomal Proteins, Non-HistoneDNA-Binding ProteinsDNA DamageDNA ReplicationHEK293 CellsHumansMinichromosome Maintenance Complex Component 4PhosphorylationProtein Kinase InhibitorsProtein Serine-Threonine KinasesReplication OriginRNA InterferenceAtaxia Telangiectasia Mutated ProteinsATR protein, humanCDC7 protein, humanCell Cycle ProteinsCheckpoint Kinase 1CHEK1 protein, humanChromosomal Proteins, Non-HistoneDNA-Binding ProteinsGINS1 protein, humanGINS2 protein, humanGINS3 protein, humanGINS4 protein, humanMCM4 protein, humanMinichromosome Maintenance Complex Component 4Protein Kinase InhibitorsProtein Serine-Threonine KinasesRNA, Small InterferingWDHD1 protein, human

Identifiers

PMID29123096
PMCPMC5680267
OpenAlexW2766757818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.